Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
41.90
+0.45 (1.09%)
Feb 3, 2026, 3:00 PM CST

SHA:600211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,0401,6481,8601,140764.41768.52
Trading Asset Securities
1,231976.62515.34792.49537.8714.96
Cash & Short-Term Investments
3,2712,6252,3751,9321,302783.48
Cash Growth
26.29%10.51%22.92%48.38%66.22%-5.64%
Accounts Receivable
596.79732.82856.71625.68632.32476.66
Other Receivables
18.2811.8511.8212.6312.8312.1
Receivables
615.07744.67868.52638.31645.15488.76
Inventory
174.65134.19111.4399.95137.3270.85
Prepaid Expenses
-0.310.011.5--
Other Current Assets
84.8565.9147.7740.0497.168.02
Total Current Assets
4,1463,5703,4032,7122,1821,351
Property, Plant & Equipment
662.68669.85600.33551.38764.54204.46
Long-Term Investments
426.36132.94116.62129.75130.25139.07
Goodwill
91.298.888.888.888.888.88
Other Intangible Assets
313.39184.09202.46416.48411.66943.46
Long-Term Deferred Tax Assets
144.2151.05115.4871.3467.1623.44
Long-Term Deferred Charges
4.082.631.932.7947.6921.53
Other Long-Term Assets
28.827.99138.79206.96190.57252.35
Total Assets
5,8164,7474,5874,1003,8032,944
Accounts Payable
32.713.55.5114.3713.227.19
Accrued Expenses
21.46377.65530.39412.7398.67271.15
Short-Term Debt
966.97272.17499.99486.1534.66-
Current Portion of Leases
0.410.920.8812.13-
Current Income Taxes Payable
45.7525.545.3127.1322.1311.45
Current Unearned Revenue
5.674.919.845.343.293.64
Other Current Liabilities
299.771.9292.5679.56135.5639.65
Total Current Liabilities
1,373766.571,1841,0261,110333.08
Long-Term Debt
-----10.42
Long-Term Leases
0.190.31.131.141.86-
Long-Term Unearned Revenue
28.827.3625.8527.5330.510.76
Long-Term Deferred Tax Liabilities
42.312.2914.0115.611.65
Other Long-Term Liabilities
431.61-----
Total Liabilities
1,876795.231,2141,0691,158355.91
Common Stock
322.32322.32247.94247.94247.94247.94
Additional Paid-In Capital
717.191,1881,2631,2661,2651,264
Retained Earnings
2,4482,3301,7731,4551,1691,086
Comprehensive Income & Other
63.6877.5761.2142.98-51.42-22.41
Total Common Equity
3,5513,9183,3453,0122,6302,576
Minority Interest
389.3234.2929.0319.0314.6612.3
Shareholders' Equity
3,9413,9523,3743,0312,6452,588
Total Liabilities & Equity
5,8164,7474,5874,1003,8032,944
Total Debt
967.57273.39501.99488.25538.6510.42
Net Cash (Debt)
2,3032,3511,8731,444763.63773.07
Net Cash Growth
11.82%25.54%29.71%89.11%-1.22%-6.90%
Net Cash Per Share
7.147.295.804.482.362.40
Filing Date Shares Outstanding
322.32322.32322.32322.32322.32322.32
Total Common Shares Outstanding
322.32322.32322.32322.32322.32322.32
Working Capital
2,7732,8032,2181,6861,0721,018
Book Value Per Share
11.0212.1610.389.348.167.99
Tangible Book Value
3,1473,7253,1332,5862,2101,624
Tangible Book Value Per Share
9.7611.569.728.026.865.04
Buildings
-580.07462.4389.99439.89150.59
Machinery
-447.84446.34139.22159.08112.38
Construction In Progress
-65.0660.71153.6272.1355.45
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.